Summary: | <p>Abstract</p> <p>Intravesical administration of <it>Bacillus Calmette-Guérin </it>is used as a treatment method in superficial bladder cancer. While it is generally well tolerated, serious side effects may develop. Granulomatous hepatitis cases have been previously reported; however, only one case with tuberculous peritonitis exists in the current literature. We hereby present two cases, one of which is the second tubercular peritonitis case following <it>Bacillus Calmette-Guérin </it>treatment to be reported, and the other a case with granulomatous hepatitis. Complete cure was achieved in both cases with specific therapy. In the patient who developed peritonitis, intravesical <it>Bacillus Calmette-Guérin </it>therapy was recommenced after antituberculosis treatment, and completed without further complications.</p>
|